The pancreatic cancer continues to represent an important problem, as a cancer with extremely poor prognosis.
INTRODUCTION
Adenocarcinoma of the pancreas continues to represent an important problem worldwide. It is a disease with an extremely poor prognosis: fewer than 20% of affected patients survive the first year, and only 3% are alive five years after the diagnosis1.
Despite this grim outcome, considerable progress has been made in our understanding of the pathogenesis of this disease with the lowest five-year survival rate.
However, an overview of current experimental and clinical results does offer some promise for the development of more effective drug combinations or combined modality regimens for systemic and local therapy. We present herein the most recent data about the experimental and clinical models of pancreatic carcinogenesis and also some comments about the therapeutic approach to pancreatic cancer.
MODELS OF EXPERIMENTAL CARCINOGENESIS IN PANCREATIC CANCER
The malignant tumors of the pancreas in humans are adenocarcinomas from pancreatic ductal cells in 3 (BPH) and the N-nitroso (2-hydroxypropyl)-2-oxoptopyl amine (HPOP) which are the most potent carcinogens in rat and hamster animal models13. It has been suggested that these N-nitroso compounds reach the pancreas either through the blood or through refluxed bile that is in contact with the pancreatic duct1. These nitrosamines can be administrated by an only intra-venous injection or repeated injections3.
The delay before the cancer is apparent after the introduction of the carcinogen may vary from one month for the focal histologic lesions, to 4-6 months for lesions > 3mm and finally plus to 1 year for the invasive pancreatic tumor2.
Carcinogenesis in Rat Models
The most used compound is the o-diazoacetyl-N serine (azaserine). Injecting as an only dose intraperitoneously (IP) in rats produces DNA alterations during the first hour and these alterations persist for 4 weeks and the DNA repair is completed after 9 weeks. In vitro doses of 30/g/ml, produce DNA alterations in cellular pancreatic lines2.
The principal target of azaserine is the acinar cell and the mode of action is the alkylation of DNA. Therefore it is evident that the most frequent histologic pancreatic lesions are nodular acinar cell atypia. These The restriction of calories inhibits carcinogenesis 2'5'1.
Proteins
The rats having a diet rich in proteins (50%) have a lower incidence of cancer. In the contrary diets poor in proteins don't have this effect5. In hamsters fed on a low-protein diet, the incidence of pancreatic adenocarcinomas and in situ carcinomas was only 13% as compared to 46% in those fed a high protein diet4.
Lipids
The effect of a diet rich in lipids on pancreatic carcinogenesis is variable5'42'43. Dietary unsaturated fat enhances pancreatic carcinogenesis43. It has been shown that a diet of 20% unsaturated fat compared to a 20% saturated fat diet or a control diet (5% unsaturated fat) increased the number of acidophilic acinar loci44.
Trypsin Inhibitors
Research and public attention have been increasingly focussed on the hypothesis that vitamins and micronutrients may decrease the incidence of some cancers of epithelial origin such as adenocarcinomas of the pancreas. A few studies have been reported concerning the possible inhibitory effects of synthetic retinoids on growth of (pre) neoplastic pancreatic lesions induced in rats and hamsters by carcinogens. Depending on both the animal model employed and the sex of the animals, synthetic retinoids have been found to enhance, to inhibit or to have no effect on 45 46 pancreatic carcinogenesis
The conflicting nature of these data may be ascribed to a difference in the types of retinoids used or a difference in the basal diets used, since in most studies impure (natural ingredients) commercial laboratory diets were used, which may vary in the amount of (un) saturated fat they contain.
The effects of vitamins A, C and E on pancreatic carcinogenesis were studied in rats and hamsters maintained on a semipurified diet high in saturated fat (20%) and it is concluded that vitamins A and C have an inhibitory effect on growth of acidophilic foci in rats and incidence of early lesions in hamsters. Vitamin E does not have a potential protective effect on pancreatic carcinogenesis in hamsters47.
Birt et al. 48 found a reduction in pancreatic adenoma incidence by feeding retinoids to female hamsters, whereas in male hamsters an increase in the incidence of adenomas was observed. They found a consistently elevated incidence of pancreatic carcinoma in males in another experiment and concluded that retinoids enhance pancreatic tumor yields in males to a greater extent than in females49.
Longnecker et al. 46 '50'51 also demonstrated inhibition of pancreatic carcinogenesis in the azaserine rat model by a number of retinoids and that selenium enhances this inhibition.
A great deal of public and scientific controversy was generated by a report published 10 years ago that coffee consumption could contribute to the development of pancreatic cancer53. In a recent comprehensive review, Gordis 
